期刊文献+

基层医院产超广谱β-内酰胺酶肺炎克雷伯杆菌医院感染及耐药性变迁 被引量:5

Hospital infection and resistance change of extended spectum β-lactamases producing Klebsiella pneumoniae in primary hospitals
原文传递
导出
摘要 目的了解产超广谱β-内酰胺酶(ESBLs)肺炎克雷伯杆菌在基层医院临床标本中的分布及其耐药趋势。方法用全自动微生物分析系统进行菌种鉴定及药物敏感性检测,采用K-B纸片扩散法检测ESBLs,采用改良Hodge试验检测菌株产碳青霉烯酶,并按年度统计其感染率及耐药性。结果 2011年至2014年肺炎克雷伯杆菌产ESBLs的检出率分别为17.05%、17.76%、27.05%和30.93%,平均为25.04%。标本来源主要为痰,占67.84%;科室分布以ICU、神经内科、呼吸内科为主,分别为34.50%、20.47%和12.28%。对常用抗生素的耐药性总体呈升高趋势,2013年和2014年共检出10株对碳青霉烯类药物耐药菌株。结论医院产ESBLs肺炎克雷伯杆菌数量及检出率逐年升高,多重耐药日趋严重,临床应加强细菌耐药监测,科学合理应用抗菌药物,延缓细菌耐药性的变迁,预防和控制医院感染扩散。 Objective To explore the clinical distribution and resistance trend of extended spectrumβ-lactamases(ESBLs)producing Klebsiella pneumoniae in primary hospitals.Methods The bacteria identification and drug sensitivity test were done by automatic microbial analysis system.K-B disc diffusion method was used to screen ESBLs and modified hodge method to screen carbapenemase-producing strains.The infection rate and the drug resistance rate were analyzed on a yearly basis.Results The detection rates of ESBLs-producing Klebsiella pneumoniae from 2011 to 2014were 17.05%,17.76%,27.05% and 30.93%respectively,about 25.04% on average.Sputum specimens were the main sources,accounting for 67.84%.ICU,neurology and respiratory medicine departments were the main sources of the specimens,accounting for34.50%,20.47% and 12.28%respectively.The resistances to commonly used antiotics showed an increasing trend.10carbapenem-resistant strains were detected in 2013 and 2014.Conclusion The number and detection rate of ESBLs-producing Klebsiella pneumoniae increased year by year,and the multi-drug resistance has become increasingly serious.Clinical monitoring of bacterial drug resistance should be strengthened,and antibacterial drugs should be scientifically and rationally used to put off the change of drug resistance and to prevent and control the spread of hospital infections.
机构地区 义乌市中医医院
出处 《中国微生态学杂志》 CAS CSCD 2016年第2期210-212,共3页 Chinese Journal of Microecology
关键词 肺炎克雷伯杆菌 超广谱Β-内酰胺酶 耐药性 Klebsiella pneumoniae Extended spectrumβ-lactamases Drug resistance
  • 相关文献

参考文献7

二级参考文献29

  • 1李平,董振芳,于行堂,白雪丽,宋晓斐.烧伤患者感染产超广谱β-内酰胺酶肺炎克雷伯菌检测及质粒图谱分析[J].中华医院感染学杂志,2007,17(4):382-384. 被引量:6
  • 2王玉红,邓敏,曾吉.肺炎克雷伯菌耐药机制研究进展[J].中华医院感染学杂志,2007,17(4):478-480. 被引量:43
  • 3National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S].9th informational supplement. Wayne, PA: NCCLS,1999.
  • 4Yagi T, Kurokawa H. A preliminary survey of extended-spectrum L-lactamases (ESBLs)in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan[J]. FEMS Microbiol Lett, 2000,184:54-55.
  • 5Knothe H, Shsh P, Kremery V, etal. Transferable to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens [J].Infection, 1983, 11:315.
  • 6Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access[J]. Curr Clin Top Infect Dis, 1992,12(1):83-110.
  • 7Mermel LA, Farr BM. Guidelines for the management of intravascular catheter-related infections [ J]. Clin Infect Dis,2001,32(5): 1249-1272.
  • 8Saint S, Matthay MA. Risk reduction in the intensive care unit[J]. Am J Med, 1998, 105(6): 515-523.
  • 9Richet H, HubertB, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients[J]. J Clin Microbiol, 1990,28(1):2520-2525.
  • 10Gil RT, Kruse JA, Thill Baharozian MC, et al. Tripleangle-lumen central venous catheters. A prospective study in a critically ill population[J]. Arch Intern Med, 1989,149(5): 1139-1143.

共引文献141

同被引文献46

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部